基本資料
種類: ETF
費用比率%: 0.09
資產淨值: 4,733.68
成立日期: 26/01/2004
 
分析
市值分佈:
95.66%
大市值
2.86%
中市值
0.65%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 25/04/2026 06:00) 總持有投資項目: 405  
0%
 
100%
     10大 (50.46%)
代號 名稱 佔比% 持有日期
HNGEHinge Health Inc.0.0131/03/2026
MBXMBX Biosciences Inc.0.0131/03/2026
ANNXAnnexon0.0131/03/2026
AVNSAvanos Medical0.0131/03/2026
ESPREsperion Therapeutics0.0131/03/2026
ABUSArbutus Biopharma Corp0.0131/03/2026
ATRI--0.0131/07/2024
IARTIntegra LifeSciences Holdings Corp0.0131/03/2026
TBPHTheravance Biopharma0.0131/03/2026
EHABEnhabit0.0131/03/2026
TSHATaysha Gene Therapies0.0131/03/2026
XNCRXencor0.0131/03/2026
KURAKura Oncology0.0131/03/2026
STAASTAAR Surgical Company0.0131/03/2026
MLTXMoonLake Immunotherapeutics0.0131/03/2026
TCMDTactile Systems Technology0.0131/03/2026
ARVNArvinas0.0131/03/2026
OCGNOcugen0.0131/03/2026
OLMAOlema Pharmaceuticals0.0131/03/2026
KALVKalVista Pharmaceuticals0.0131/03/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14   15    16    17    18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.